A detailed history of Geode Capital Management, LLC transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 424,832 shares of VOR stock, worth $301,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares
424,832
Previous 841,208 49.5%
Holding current value
$301,630
Previous $1.99 Million 78.73%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$1.0 - $2.2 $416,376 - $916,027
-416,376 Reduced 49.5%
424,832 $424,000
Q1 2024

May 13, 2024

BUY
$1.8 - $2.85 $84,861 - $134,363
47,145 Added 5.94%
841,208 $1.99 Million
Q4 2023

Feb 13, 2024

BUY
$1.66 - $2.63 $62,600 - $99,179
37,711 Added 4.99%
794,063 $1.79 Million
Q3 2023

Nov 13, 2023

BUY
$2.1 - $3.35 $71,288 - $113,722
33,947 Added 4.7%
756,352 $1.6 Million
Q2 2023

Aug 11, 2023

BUY
$3.09 - $5.33 $1.26 Million - $2.17 Million
406,458 Added 128.65%
722,405 $2.23 Million
Q1 2023

May 15, 2023

BUY
$4.68 - $6.96 $698,171 - $1.04 Million
149,182 Added 89.46%
315,947 $1.7 Million
Q4 2022

Feb 13, 2023

BUY
$3.77 - $7.43 $117,499 - $231,570
31,167 Added 22.98%
166,765 $1.11 Million
Q3 2022

Nov 14, 2022

BUY
$3.9 - $5.52 $110,069 - $155,790
28,223 Added 26.28%
135,598 $539,000
Q2 2022

Aug 12, 2022

SELL
$3.89 - $6.44 $582,041 - $963,585
-149,625 Reduced 58.22%
107,375 $533,000
Q1 2022

May 13, 2022

BUY
$6.04 - $12.23 $37,599 - $76,131
6,225 Added 2.48%
257,000 $1.55 Million
Q4 2021

Feb 11, 2022

SELL
$11.32 - $18.02 $239,553 - $381,339
-21,162 Reduced 7.78%
250,775 $2.91 Million
Q3 2021

Nov 12, 2021

BUY
$12.24 - $20.38 $945,062 - $1.57 Million
77,211 Added 39.65%
271,937 $4.26 Million
Q2 2021

Aug 13, 2021

BUY
$18.65 - $38.78 $121,430 - $252,496
6,511 Added 3.46%
194,726 $3.63 Million
Q1 2021

May 12, 2021

BUY
$30.96 - $54.08 $5.83 Million - $10.2 Million
188,215 New
188,215 $8.11 Million

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $27M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.